14 July 2010


Riber sells MBE reactors to two European research institutes

Riber S.A. of Bezons, France, which manufactures molecular beam epitaxy (MBE) systems as well as evaporation sources and effusion cells, says that it has received orders from two European research institutes: one for a Compact 21 reactor and one for an Epineat reactor.

Riber claims that the Compact 21 (said to be the world's best-selling MBE research reactor) offers unrivalled flexibility for use in the ultra-vacuum development of compound semiconductors.

The firm adds that the Epineat range of systems represents the most effective solution for the small-scale development or production of compound semiconductor materials on 4-inch substrates.

Riber concludes that the new orders back up its business model and strategy, based on:

  • capitalizing on the installed base and growing sales of epitaxy equipment, spare parts and accessories, as well as corresponding services;
  • launching a range of high value-added equipment and services for high-growth application fields (thin-film solar cells, organic LED lighting and displays etc).

See related item:

Riber reports Q1 revenue up 11% year-on-year

Search: Riber MBE Compact 21 Epineat